2009 Innovation Intangible Assets Marketing 
Harvard Business Review
JUNE 16, 2011
So it is with most breakthrough innovations and banner financial years. Interestingly, intangible assets are all the rage these days on Wall Street. There is no line on the balance sheet for "ability to innovate" or "skill at managing brand." If ego and time allow, the list can be quite long.
Harvard Business Review
NOVEMBER 21, 2013
For many years, beginning in 1942, Premarin was the only hormone replacement therapy drug on the market derived from a natural source. Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Why do some companies choose to patent their innovation while others choose to hide it?
Expert insights. Personalized for you.
15 
Let's personalize your content